EVOLVING ALZHEIMER’S DISEASE MANAGEMENT
As the population ages, the risk of Alzheimer’s disease (AD) is elevated and the need for new approaches to management increases.1
AD is a burden for patients, caregivers, and the healthcare system1
An estimated 5.8 million Americans over the age of 65 are living with dementia due to AD. That number is projected to reach 13.8 million by 2050.1
Alzheimer’s Disease Prevalence and Economic Data by State1
Alabama
Projected Number of Patients:
In 2020
96,000
In 2025
110,000
Survey from 2019
306,000
Caregivers*
$4.58 billion
Value of Unpaid Care*
*State totals may not add to the US total due to rounding.
In 2020, direct costs for Alzheimer's disease and other dementias are estimated at $305 billion1
On a yearly basis, the costs for Medicare/Medicaid beneficiaries with AD dementia or other dementias for healthcare services like hospitals, nursing homes, hospice, and home healthcare are significantly greater than for people without dementia.
If left unaddressed, total annual payments for healthcare, long-term care, and hospice care for people with AD and other dementias are projected to increase to more than $1.1 trillion in 2050.
Increased prevalence will place greater demands on healthcare providers1
Recent analysis suggests that the US has approximately half the number of geriatricians needed and that only a small percentage of nurse practitioners, social workers, and other professionals are skilled in working with older adults.
According to one estimate, the US is projected to need three times the current number of geriatricians by 2050.¹
ATTENTION
An error occurred while rendering this component.
Please consult your application support team.
Preparing the healthcare infrastructure for the potential arrival of new treatment is an important next step for addressing the challenges of AD.
Request more information
Receive updated news and perspectives about Alzheimer’s disease
